MedDataX Logo

A Prospective Multicenter Study to Evaluate Usefulness of Cardio-Ankle Vascular Index in Japan

NCT01859897 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3026

Last updated 2020-09-25

No results posted yet for this study

Summary

The objective of this five-year prospective observational follow-up study is to examine the additional benefits of using cardio-ankle vascular index (CAVI) as a predictive indicator of cardiovascular events in high-risk patients.

Conditions

  • Stroke
  • Cardiovascular Death
  • Nonfatal Myocardial Infarction

Sponsors & Collaborators

  • Toho University

    collaborator OTHER

  • Ehime University Graduate School of Medicine

    collaborator OTHER

  • Dokkyo Medical University

    collaborator OTHER

  • Okayama University

    collaborator OTHER

  • CAVI-J Study Group

    lead OTHER

Principal Investigators

  • Hajime Orimo, MD · Kenkoin Clinic

Eligibility

Min Age
40 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2019-06-30
Completion
2020-04-30

Countries

  • Japan

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01859897 on ClinicalTrials.gov